Skip to main content
FinSpry Logo
FinSpry
WGS logo
WGS
(NASDAQ)
GeneDx Holdings Corp.
$42.13-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

GeneDx Holdings (WGS) Stock Price & Financial Analysis

GeneDx Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$41.40 - $43.77
52-Week High$170.87
52-Week Low$32.21
Open$42.72
Volume1.66M
Average Volume (3M)1.52M
Market Cap1.20B
Shares Outstanding29.34M
Price to Sales (P/S)2.70
Price to Book (P/B)4.70
EV/EBITDA-29.44
Revenue (TTM)442.68M
Net Income (TTM)-77.81M
Free Cash Flow (TTM)-28.65M
EPS (TTM)$-2.71
Profit Margin-17.58%
Operating Margin-14.79%
Return on Equity (ROE)-30.62%
Debt to Equity0.38
50-Day MA$66.11
200-Day MA$107.75
52-Week Change-32.86%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About GeneDx Holdings

What is the current stock price for WGS?

As of the latest trading session, WGS stock trades at $42.13. The 52-week range is $32.21–$170.87, with a day range of $41.40–$43.77.

What is the P/E ratio for WGS?

The P/E ratio (Price-to-Earnings) for WGS is shown in the Key Statistics section. This valuation metric helps compare GeneDx Holdings Corp. to industry peers.

Does WGS pay dividends?

GeneDx Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for WGS?

Based on 4 analysts, the consensus for WGS is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of WGS?

GeneDx Holdings's market capitalization is $1.24B, classifying it as a small-cap company. GeneDx Holdings operates in the Healthcare sector within the Diagnostics & Research industry.